My father once said, “of all the forms of inequality, injustice in health care is the most shocking and inhumane.” Today, those words highlight a significant public health issue in our country.
Millions in America face obesity, a chronic disease impacting low-income and minority communities disproportionately. Unfortunately, many of these individuals lack access to effective treatments.
This issue transcends mere health care; it is fundamentally about fairness and equal opportunity. Some states, including California, have recently limited coverage for GLP-1 treatments for obesity. This decision illustrates a broader challenge: effective care is often accessible only to those with financial means.
We often express that income or location should not dictate one’s ability to maintain good health. Yet, if effective obesity treatments are mostly for those with private insurance or those who can pay, these principles lose their value.
Access to treatment heavily depends on income. Obesity is linked to various chronic conditions like heart disease, stroke, diabetes, kidney disease, and hypertension. These conditions lead to suffering, financial strain, and increased health care costs.
Recent advancements in obesity treatment offer hope, aiding many in managing this chronic disease. This is about accessing essential medical care, not merely appearance.
Parents gain the vitality to care for their children. Workers improve their health and job performance. Patients, after years of ineffective treatments, finally witness progress.
Nevertheless, if access is limited to those who can afford it, hope loses its meaning. When Medicaid excludes obesity treatments, low-income patients endure waiting until their conditions worsen. Postponing care doesn’t reduce costs; it shifts them to emergency services and preventable hardships.
Policymakers should classify obesity treatment as essential health care, not a luxury. This is crucial, especially in communities with high obesity and chronic disease rates. We can’t reduce health disparities without access to promising interventions.
Regrettably, stigma often taints our obesity discourse. Many face judgment rather than empathy. We should treat obesity as a serious chronic condition, not a moral failing.
We wouldn’t tell a cancer patient to try harder. Similarly, obesity deserves respect and accessible treatment.
Medicaid’s purpose is to ensure care is not contingent on wealth. Excluding obesity treatment subverts this mission.
The fundamental question is: Who deserves modern medicine? We can’t foster a healthier nation while neglecting the most disadvantaged communities. Broadening Medicaid coverage for obesity treatment won’t solve all health care issues. Yet, it marks progress in making medical advancements available to everyone.
A society’s measure isn’t in granting lifesaving care to the fortunate but in extending it to those in dire need.
Martin Luther King III is a global humanitarian and activist and the eldest son of the Rev. Martin Luther King Jr.
The views expressed in this article are those of the writer.